UBS downgrades BHEL shares to Neutral from Buy. Check target, key reasons

UBS has downgraded BHEL to “Neutral” from “Buy”, citing a more balanced risk-reward outlook after the stock’s strong run, though it raised the target price to Rs 460 from Rs 375, implying about 14% upside. The brokerage believes much of BHEL’s order book growth is already reflected in the stock price.